Biotalys NV (EBR:BTLS)
Belgium · Delayed Price · Currency is EUR 2.660
+0.090 (3.50%)
Feb 10, 2026, 12:55 PM CET
Biotalys NV Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
63
Market Cap
96.42M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Atenor | 239.81M |
| Whitestone Group | 225.86M |
| Brouwerij Handelsmaatschappij NV | 110.20M |
| Banqup Group | 79.56M |
| Hybrid Software Group | 51.17M |
| Payton Planar Magnetics | 39.07M |
| Ekopak NV | 36.74M |
| Texaf | 33.88M |
Biotalys NV News
- 2 months ago - Biotalys Secures EPA Approval For EVOCA, First Protein-Based Biofungicide - Nasdaq